Clinical Trials Logo

Bipolar, Mania clinical trials

View clinical trials related to Bipolar, Mania.

Filter by:
  • None
  • Page 1

NCT ID: NCT01621165 Withdrawn - Bipolar, Mania Clinical Trials

Prazosin as an Antimanic Agent in Severe Mania or Mixed States

Start date: March 2009
Phase: N/A
Study type: Interventional

Mania has been considered to be, in part, a hyperadrenergic state. One focus of treatment of mania involves directly targeting this hyperexcitable state by reducing arousal with antiadrenergic agents. This can be achieved by decreasing norepinephrine release by stimulating presynaptic inhibitory receptors. Prazosin, FDA approved for the treatment of high blood pressure works in part by blocking postsynaptic alpha-adrenergic receptors. Prazosin has been found to be clinically useful for the treatment of Post Traumatic Stress Disorder. It is reasonable, therefore, to anticipate that prazosin might be helpful in the treatment of mania.

NCT ID: NCT01043679 Recruiting - Bipolar, Mania Clinical Trials

Efficacy and Safety of Utapine vs. Seroquel in Patients With Bipolar Mania

UtapMani
Start date: July 2009
Phase: Phase 4
Study type: Interventional

The goal of this research is to evaluate the safety as well as effectiveness of Utapine and Seroquel in bipolar I disorder patients.

NCT ID: NCT00280566 Completed - Bipolar Disorder Clinical Trials

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Start date: December 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if ziprasidone plus a mood stabilizer will continue to be a safe and effective treatment regimen for adults with Bipolar I Disorder (manic or mixed symptoms) after they have achieved 8 consecutive weeks of symptom improvement on the regimen.